Improved statistical signal detection in pharmacovigilance by combining multiple strength-of-evidence aspects in vigiRank.
about
Computational approaches for pharmacovigilance signal detection: toward integrated and semantically-enriched frameworksAllergy-Like Immediate Reactions with Herbal Medicines: A Retrospective Study Using Data from VigiBase®.Use of logistic regression to combine two causality criteria for signal detection in vaccine spontaneous report data.Good Signal Detection Practices: Evidence from IMI PROTECTA method for systematic discovery of adverse drug events from clinical notesLongitudinal medical records as a complement to routine drug safety signal analysis.Pharmacoepidemiological considerations in observed-to-expected analyses for vaccines.Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases.vigiRank for statistical signal detection in pharmacovigilance: First results from prospective real-world use.Decision making in drug safety-a literature review of criteria used to prioritize newly detected safety issues.The 9th Biennial Conference on Signal Detection and Interpretation in Pharmacovigilance.Cheminformatics-aided pharmacovigilance: application to Stevens-Johnson Syndrome.What Is the Plural of a 'Yellow' Anecdote?A prediction model-based algorithm for computer-assisted database screening of adverse drug reactions in the Netherlands.An Automated System Combining Safety Signal Detection and Prioritization from Healthcare Databases: A Pilot Study.Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database.
P2860
Q28651547-DEAD353E-036B-4C59-8CF5-8B10845F98FEQ31051777-E9378749-ACA2-457D-9886-3D6EB01BCD7DQ34567443-6889FC75-CAC3-48E3-8718-4417252BC010Q36914069-3285DC53-19C5-4FAC-A7E0-231A625478AEQ37040215-DBF4C2A2-0DA7-4087-BBB9-9526F73EAC1FQ37257431-C756D6E8-671F-4CB9-AC35-5321C0EBD29EQ37337367-82FB4703-C238-48F0-BE07-DE9ABEE72075Q38410419-7E183BA3-2090-45CD-8467-3626CD61C832Q38707428-4E358C83-C92B-4594-B7D2-BA6950368BAEQ39017851-DFCE438E-D921-4203-8202-6755A673587EQ40088246-78ED141A-3E65-442F-89D9-668114574D60Q41226295-25933B62-1652-40BE-8EDF-179548C5AB4FQ44282365-59EC91F8-F9D5-45B1-B52B-0FD5F0065B90Q47261092-93946B91-5719-4D10-96E9-172C2E662A66Q47399072-259F33DB-94FC-401D-AC06-FD5857374B2FQ47950575-3639B911-7D39-4C14-BD14-93CD4BA77234Q48174494-505AFF7D-73EA-4E92-947B-51342D6BBC0BQ55433227-DFFAFE8A-474C-4F1B-A860-62E48AAC5E8F
P2860
Improved statistical signal detection in pharmacovigilance by combining multiple strength-of-evidence aspects in vigiRank.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Improved statistical signal de ...... -evidence aspects in vigiRank.
@ast
Improved statistical signal de ...... -evidence aspects in vigiRank.
@en
Improved statistical signal de ...... -evidence aspects in vigiRank.
@nl
type
label
Improved statistical signal de ...... -evidence aspects in vigiRank.
@ast
Improved statistical signal de ...... -evidence aspects in vigiRank.
@en
Improved statistical signal de ...... -evidence aspects in vigiRank.
@nl
prefLabel
Improved statistical signal de ...... -evidence aspects in vigiRank.
@ast
Improved statistical signal de ...... -evidence aspects in vigiRank.
@en
Improved statistical signal de ...... -evidence aspects in vigiRank.
@nl
P2093
P2860
P1433
P1476
Improved statistical signal de ...... f-evidence aspects in vigiRank
@en
P2093
Kristina Juhlin
Ola Caster
Sarah Watson
P2860
P2888
P304
P356
10.1007/S40264-014-0204-5
P577
2014-08-01T00:00:00Z
P5875
P6179
1053257259